Simple scenario to me!
OCC have a product that has proven to be effective.
OCC have collaboration with a subsidiary of Johnson & Johnson, which has to not only assist with research, but surely with future market penetration and distribution.
Don't care about day traders, just see OCC as a giant medical company of the future.
Wait and be rewarded.
Ann: CelGro Study Validates High Quality Nerve Repair, page-41
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.39 |
Change
0.120(9.45%) |
Mkt cap ! $333.1M | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.40 | $1.27 | $1.253M | 925.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.39 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 5925 | 2 |
View Market Depth
| Last trade - 16.10pm 27/12/2024 (20 minute delay) ? |
| OCC (ASX) Chart |
